Atlas Trials

A Relative Bioavailability Study of Griseofulvin 125 mg/5 mL Suspension Under Non-fasting Conditions

Clinical trial NCT00863863 · COMPLETED

Trial details

NCT number
NCT00863863
Sponsor
Actavis Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2006-01-01
Primary completion
2006-01-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.